oppBJA-2018-13607-cfda16.838-cidBJA-2018-13891-instructions..pdf

PDF 396 KB Posted

Attached to
BJA FY 18 Comprehensive Opioid Abuse Site-based Program
Opportunity number
BJA-2018-13607
Issued by

About this file

Application Instructions

View the file

Other files

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

OMB No. 1121-0329 U.S. Department of Justice Approval Expires 11/30/2020 Office of Justice Programs Bureau of Justice Assistance

The U.S. Department of Justice (DOJ), Office of Justice Programs (OJP), Bureau of Justice Assistance (BJA), in partnership with the Office for Victims of Crime (OVC), is seeking applications to plan and implement comprehensive programs in response to the growing opioid epidemic. This program furthers the Department’s mission by providing resources to support state, local, tribal, and territorial efforts to reduce violent crime and drug abuse and enhance public safety, while supporting victims.

Comprehensive Opioid Abuse Site-based Program

FY 2018 Competitive Grant Announcement Applications Due: June 7, 2018

Eligibility

Eligible applicants are those that meet the following criteria for the six categories:

Category 1: First Responder Partnerships – Applicants are limited to units of local government and federally recognized Indian tribal governments (as determined by the Secretary of the Interior). Jurisdictions without a county- or local government-based addiction service system may designate the State Administering Agency (SAA) to serve as the primary applicant and subgrant funds to providers at the county level.

Category 2: Technology-assisted Treatment Projects – Applicants are limited to state agencies. State agencies include state administrative offices, state criminal justice agencies, and other state agencies involved with the provision of substance abuse treatment services to individuals who come in contact with the criminal justice system such as the SAA, the Administrative Office of the Courts, and the State Alcohol and Substance Abuse Agency.

Category 3: System-level Diversion Projects – Applicants are limited to units of local government and federally recognized Indian tribal governments (as determined by the Secretary of the Interior). Jurisdictions without a county- or local government-based addiction service system may designate the SAA to serve as the primary applicant and subgrant funds to providers at the county level. BJA recognizes that there are at least 41 cities around the country that are not within a county system, which are also eligible to apply.

Category 4: Statewide Planning, Coordination, and Implementation Projects – Applicants are limited to the SAA responsible for directing criminal justice planning or the State Alcohol and Substance Abuse Agency.

http://www.justice.gov/ http://www.ojp.gov/ https://www.bja.gov/ https://www.bja.gov/ https://ojp.gov/saa/

BJA-2018-13607

Category 5: Harold Rogers Prescription Drug Monitoring Program (PDMP) Implementation and Enhancement Projects – Applicants are limited to state governments and territories that have a pending or enacted enabling statute or regulation requiring the submission of controlled substance prescription data to an authorized state agency. Applicants within a state that does not have an enabling state statute requiring the submission of controlled substance prescription data to an authorized state agency are eligible to apply as a city, county, or region if (a) the city, county, or region has enacted an enabling statute, ordinance, or regulation requiring the submission of controlled substance prescription data to an authorized city, county, or region; (b) the city, county, or region agrees to transition the PDMP system to an authorized state agency if the state adopts an enabling state statute requiring the submission of controlled substance prescription data to an authorized state agency; and (c) ensures that all vendor contracts are written to permit the transfer of ownership of the system to the authorized state agency.

Category 6: Public Safety, Behavioral Health, and Public Health Information-sharing Partnerships – Applicants are limited to state agencies and units of local government located in states with existing and operational prescription drug monitoring programs and federally recognized Indian tribal governments (as determined by the Secretary of the Interior).

For any of the categories listed above, BJA welcomes applications under which two or more entities would carry out the federal award; however, only one entity may be the applicant. Any others must be proposed as subrecipients (“subgrantees").1 The applicant must be the entity that would have primary responsibility for carrying out the award, including administering the funding and managing the entire project. Under this category, only one application by any particular applicant entity will be considered. An entity may, however, be proposed as a subrecipient (subgrantee) in more than one application. This includes applications that propose to serve a region that crosses state boundaries. Subrecipients may include treatment providers, victim service providers, and other not-for-profit entities as part of a comprehensive cross-disciplinary response as outlined in Categories 1–4 and Category 6.

An agency should submit only one application per category. If an agency wishes to apply under multiple categories, a separate application is needed for each category of funding.

NOTE: In addition to this announcement, in fiscal year (FY) 2018, BJA is offering solicitations for Drug Courts and Veterans Treatment Courts, Residential Substance Abuse Treatment, Strategies for Policing Innovation, Innovations in Prosecution, and Second Chance Act reentry initiatives. These solicitations may be relevant to potential applicants seeking to implement specific drug-related strategies. Eligible applicants are encouraged to review these other solicitations as they are released. For more information on BJA’s current solicitations, visit:

https://www.bja.gov/funding.aspx#1.

NOTE: The formerly standalone Harold Rogers Prescription Drug Monitoring grant program has been incorporated into the FY 2018 Comprehensive Opioid Abuse Site-based Program solicitation as Categories 5 and 6 of funding.

1 For additional information on subawards, see "Budget and Associated Documentation" under Section D.

Application and Submission Information.

https://www.bja.gov/funding.aspx#1

BJA may elect to fund applications submitted under this FY 2018 solicitation in future fiscal years, dependent on, among other considerations, the merit of the applications and on the availability of appropriations.

Deadline

Applicants must register with Grants.gov at https://www.grants.gov/web/grants/register.html prior to submitting an application. All applications are due by 11:59 p.m. eastern time on June 7, 2018.

To be considered timely, an application must be submitted by the application deadline using Grants.gov, and the applicant must have received a validation message from Grants.gov that indicates successful and timely submission. OJP urges applicants to submit applications at least 72 hours prior to the application due date, to allow time for the applicant to receive validation messages or rejection notifications from Grants.gov, and to correct in a timely fashion any problems that may have caused a rejection notification.

OJP encourages all applicants to read this Important Notice: Applying for Grants in Grants.gov.

For additional information, see How To Apply in Section D. Application and Submission Information.

Contact Information

For technical assistance with submitting an application, contact the Grants.gov Customer Support Hotline at 800-518-4726 or 606-545-5035, at https://www.grants.gov/web/grants/support.html, or via email to support@grants.gov. The Grants.gov Support Hotline hours of operation are 24 hours a day, 7 days a week, except on federal holidays.

An applicant that experiences unforeseen Grants.gov technical issues beyond its control that prevent it from submitting its application by the deadline must email the contact identified below within 24 hours after the application deadline to request approval to submit its application after the deadline. Additional information on reporting technical issues appears under “Experiencing Unforeseen Grants.gov Technical Issues” in the How To Apply section.

For assistance with any unforeseen Grants.gov technical issues beyond an applicant’s control that prevent it from submitting its application by the deadline, or any other requirement of this solicitation, contact the National Criminal Justice Reference Service (NCJRS) Response Center:

toll-free at 800–851–3420; via TTY at 301–240–6310 (hearing impaired only); email grants@ncjrs.gov; fax to 301–240–5830; or web chat at https://webcontact.ncjrs.gov/ncjchat/chat.jsp. The NCJRS Response Center hours of operation are 10:00 a.m. to 6:00 p.m. eastern time, Monday through Friday, and 10:00 a.m. to 8:00 p.m.

eastern time on the solicitation close date.

Grants.gov number assigned to this announcement: BJA-2018-13607

Release date: May 8, 2018 https://www.grants.gov/web/grants/register.html http://ojp.gov/funding/Apply/Grants-govInfo.htm https://www.grants.gov/web/grants/support.html mailto:support@grants.gov mailto:grants@ncjrs.gov https://webcontact.ncjrs.gov/ncjchat/chat.jsp

Contents A. Program Description

Overview

Program-specific Information

Objectives and Deliverables

Evidence-based Programs or Practices

Information Regarding Potential Evaluation of Programs and Activities

B. Federal Award Information

Type of Award

Financial Management and System of Internal Controls

Budget Information

Cost Sharing or Match Requirement

Pre-agreement Costs (also known as Pre-award Costs)

Limitation on Use of Award Funds for Employee Compensation; Waiver

Prior Approval, Planning, and Reporting of Conference/Meeting/Training Costs

Costs Associated with Language Assistance (if applicable)

C. Eligibility Information

D. Application and Submission Information

What an Application Should Include

How To Apply

E. Application Review Information

Review Criteria

Review Process

F. Federal Award Administration Information

Federal Award Notices

Administrative, National Policy, and Other Legal Requirements

General Information about Post-Federal Award Reporting Requirements

G. Federal Awarding Agency Contact(s)

H. Other Information

Freedom of Information Act and Privacy Act (5 U.S.C. 552 and 5 U.S.C. 552a)

Provide Feedback to OJP

Appendix A: Application Checklist

Comprehensive Opioid Abuse Site-based Program

CFDA #16.838 and CFDA #16.754

A. Program Description

Overview Signed into law on July 22, 2016, the Comprehensive Addiction and Recovery Act (CARA) is the first major federal substance abuse treatment and recovery legislation in 40 years and the most comprehensive legislative effort to address the opioid epidemic. CARA establishes a comprehensive, coordinated, and balanced strategy through enhanced grant programs that encompass prevention and education efforts, effective responses to those affected by substance abuse, and services for treatment and recovery from addiction. The Comprehensive Opioid Abuse Site-based Program (COAP) was developed as part of the CARA legislation.

COAP’s purpose is to provide financial and technical assistance to states, units of local government, and Indian tribal governments to plan, develop, and implement comprehensive efforts to identify, respond to, treat, and support those impacted by the opioid epidemic.

Note that the Harold Rogers Prescription Drug Monitoring Program (PDMP) has been incorporated into the FY 2018 Comprehensive Opioid Abuse Site-based Program. PDMPs collect, monitor, and analyze electronically transmitted prescribing and dispensing data submitted by pharmacies and dispensing practitioners. The purpose of the Harold Rogers PDMP is to improve collaboration and strategic decision-making among regulatory and law enforcement agencies and public health entities to address prescription drug and opioid abuse, save lives, and reduce crime.

Statutory Authority The Comprehensive Opioid Abuse Site-based Program was authorized by the Comprehensive Addiction Recovery Act of 2016 (CARA) (Public Law 114–198), and codified at 34 U.S.C. § 10701. The victim response and services component of Category 1 is authorized by 34 U.S.C. § 20103(c)(1)(A).

The Harold Rogers Prescription Drug Monitoring Program, which funds grant Categories 5 and 6 in this solicitation, was created by the FY 2002 U.S. Department of Justice Appropriations Act.

Awards under this solicitation will be made with funds provided through the Consolidated Appropriations Act, 2018.

Program-specific Information The opioid crisis is a public health emergency that threatens the wellbeing of individuals who abuse drugs and impacts the safety of communities. The opioid epidemic is impacting first responders, the criminal justice system, child welfare and foster care, and behavioral health systems. Responding to this epidemic is one of the Department’s top priorities. According to the Centers for Disease Control and Prevention (CDC), in 2016, there were more than 63,600 drug overdose deaths in the United States, mostly from opioids. The age-adjusted rate of drug overdose deaths in 2016 (19.8 per 100,000) was 21 percent higher than the rate in 2015 (16.3 per 100,000)2. These numbers are alarming, yet they only capture one tragic element of the epidemic—drug overdose deaths. We now know that the consequences are vast and serious and reach far beyond one person, extending to their children and families. Many factors can stem from, as well as lead to, addiction, including: poverty and economic instability; a range of physical, mental, and behavioral health ailments; decreased ability to parent and care for children; and trauma, exposure to violence, and victimization.

In response to this epidemic, the FY 2018 Comprehensive Opioid Abuse Site-based Program is designed to support our nation’s first responders and provide for the needs of crime victims;

support diversion programs for non-violent individuals who abuse illicit and prescription opioids;

implement and enhance prescription drug monitoring programs; promote cross-system planning and coordination of service delivery; and reduce the incidence of fatal overdoses associated with opioid use. Effective responses must be comprehensive and address the needs of the individual who is abusing drugs, as well as any children and loved ones who may be experiencing trauma, violence, and victimization.

COAP focuses on systemwide initiatives, as well as innovative approaches, to promote substance abuse treatment and recovery support. These concepts are rooted in the Sequential Intercept Model (https://www.prainc.com/wp-content/uploads/2015/10/SIMBrochure.pdf) developed by Mark R. Munetz, MD, and Patricia A. Griffin, PhD, in conjunction with the GAINS Center (https://www.samhsa.gov/gains-center). The Sequential Intercept Model provides a conceptual framework for communities to use when considering the interface between the criminal justice and substance abuse treatment systems. Within the criminal justice system, there are numerous intercept points—opportunities for linkage to services and for prevention of further penetration into the criminal justice system. The model shows the paths an individual may take through the criminal justice system, where the intercept points fall, and areas that communities can target for diversion, engagement, and reentry. Applicants should also review the latest expansion of the Sequential Intercept Model (https://www.prainc.com/wp-content/uploads/2016/11/Intercept-0-Infographic-2.pdf), to include Intercept 0 when designing their initiatives.

Examples of successful BJA-funded projects from past years can be found here. Applicants should note that this solicitation allows for projects broader in scope than previous projects.

Applicants can find information on evidence-based treatment practices in the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Guide to Evidence-Based Practices available at www.samhsa.gov/ebpwebguide. The Guide provides a short description and a link to dozens of websites with relevant evidence-based practices information—either specific interventions or comprehensive reviews of research findings.

PDMPs are designed to collect, monitor, and analyze electronically transmitted prescribing and dispensing data submitted by pharmacies and dispensing practitioners. This information is used to assist prescribers, dispensers, and other health care professionals in making clinical decisions for their patients. PDMPs have been shown to reduce adverse drug interactions and help health care professionals identify patients who may be in need of substance abuse treatment. Law enforcement and regulatory/licensing board officials utilize PDMP information, under appropriate circumstances, to further their investigations of suspected violations of controlled substance laws and compliance with regulatory/licensing board practice standards.

Many states have also begun to use PDMPs as a public health surveillance tool. PDMPs

2 See https://www.cdc.gov/nchs/data/databriefs/db294.pdf for more information.

https://www.prainc.com/wp-content/uploads/2015/10/SIMBrochure.pdf https://www.samhsa.gov/gains-center https://www.prainc.com/wp-content/uploads/2016/11/Intercept-0-Infographic-2.pdf https://www.prainc.com/wp-content/uploads/2016/11/Intercept-0-Infographic-2.pdf https://www.bja.gov/ProgramDetails.aspx?Program_ID=72 http://www.samhsa.gov/ebpwebguide https://www.cdc.gov/nchs/data/databriefs/db294.pdf continue to be among the most promising state-level interventions to improve opioid prescribing, inform clinical practice, and protect at-risk patients.

Research Component For Category 1, 3, and 6, BJA encourages the development of a research plan. Applicants are encouraged to partner with a researcher using an “action research” approach to enhance collection and review of data, which in turn can serve as a strong foundation for outcome evaluations of program interventions. In “action research,” researchers work closely with practitioners to most effectively address specific challenges (e.g., increased drug overdose rates or PDMP utilization). In addition, research partners work with the agency and/or consortium of partners to assess problems, identify underlying causes of these problems, develop effective strategies to address these problems, and provide “real-time” feedback to enhance decision-making.

Objectives and Deliverables The Comprehensive Opioid Abuse Site-based Program aims to reduce opioid abuse and the number of overdose fatalities, as well as to mitigate the impacts on crime victims. The program also supports the implementation, enhancement, and proactive use of prescription drug monitoring programs to support clinical decision making and prevent the abuse and diversion of controlled substances.

The objectives of COAP are to:

• Expand law enforcement and victim service partnerships.

• Encourage and support comprehensive cross-system planning and collaboration among officials who work in law enforcement, pretrial services, the courts, probation and parole, child welfare, reentry, PDMPs, and emergency medical services, as well as health care providers, public health partners, and agencies that provide substance abuse treatment and recovery support services.

• Develop and implement strategies to identify and provide treatment and recovery support services to “high frequency” utilizers of multiple systems (e.g., health care, child welfare, criminal justice) who have a history of opioid abuse.

• Expand law enforcement diversion programs.

• Expand the availability of treatment and recovery support services in rural or tribal communities by expanding the use to technology-assisted treatment and recovery support services.

• Implement and enhance prescription drug monitoring programs.

• Develop and enhance public safety, behavioral health, and public health information-sharing partnerships that leverage key public health and public safety data sets (e.g., de-identified PDMP data, naloxone administrations, fatal and non-fatal overdose data, drug arrests) and develop interventions based on this information.

Category 1: First Responder Partnerships Law enforcement and other first responders are at the front line of the opioid epidemic, responding to frequent drug overdose calls. A variety of multidisciplinary overdose response and diversion models, led by first responders, have emerged in communities throughout the nation. These models often include first responders working in partnership with substance abuse treatment providers and peer recovery coaches to help overdose victims access treatment and recovery support services.

The purpose of this category is to support multidisciplinary opioid response partnerships that include, at a minimum, a law enforcement/first responder component. Subcategory 1a supports partnerships that focus primarily on law enforcement/first responder and behavioral health and/or public health partnerships. Subcategory 1b supports partnerships that focus not only on law enforcement/first responders and behavioral health, but also on victim services and child welfare.

Applicants under Subcategory 1a may request a project period of 24 months and an award amount no greater than $500,000. Applicants under Subcategory 1b may request a project period of 24 months and an award amount no greater than $800,000. Applicants under Subcategory 1b must direct a minimum of $400,000 of the budget to victim services. Up to $400,000 must be directed to general services. The application budget must reflect the total requested funding amount for the entire grant period and not the amount per year. Applicants should fully consider the partnerships required, the logistics of establishing data sharing or data use agreements to support the proposed project, and budget for each partner’s project costs appropriately. Applicants must identify a project coordinator to manage the day-to-day operations of the initiative. Specifically, applicants should fully consider the data collection needed to support the proposed project and appropriately budget for that cost.

Mandatory Project Components and Deliverables for Category 1 All applicants under Category 1 must:

• Establish a coordinated multi-disciplinary response team that includes law enforcement and other first responders, treatment providers, and/or peer recovery specialists. Other team members may include child welfare providers, public health providers, hospital-based program providers, prosecutors, the courts, etc.

• Establish pre-arrest or post-arrest diversion programs for individuals who commit low level, non-violent offenses to community-based substance abuse and behavioral health services. There are a variety of recognized pathways to diversion. This includes self-referral, active outreach, naloxone plus, officer prevention, and officer intervention.

Examples of diversion programs that reflect these different pathways include Police Assisted Addiction and Recovery Initiative (PAARI), Quick Response Teams (QRT), Drug Abuse Response Teams (DART), Stop, Triage, Engage, Educate and Rehabilitate (STEER), and Law Enforcement Assisted Diversion (LEAD). BJA supports all models of diversion. As directed by Congress, a minimum of 2.5 million in COAP funds will be used to support communities seeking to replicate the LEAD model. Jurisdictions seeking to replicate the LEAD model should familiarize themselves with the goals and core principles of LEAD and reflect these concepts in their application.

• Identify a project coordinator who dedicates a portion of their time beyond their normal job duties to manage the day-to-day operations of the initiative during the planning and implementation phases. No less than 50 percent of the project coordinator’s time should be spent on BJA-funded project activities. The project coordinator will work closely with the selected training and technical assistance (TTA) provider to:

o Identify the needs of the community, including collecting and analyzing administrative and overdose data.

o Work with project staff to design an appropriate outreach and prevention strategy, based on the data.

o Convene regular stakeholder discussions surrounding project implementation.

o Respond to requests for data, reports, and information about the proposed initiative.

o Ensure continued project implementation and redirection, if needed.

https://www.leadbureau.org/

• Agree to work closely with BJA’s designated TTA provider(s) as well as an evaluator who may conduct a site-specific or cross-site evaluation in future years.

• Track quarterly performance measures, including measures associated with future naloxone administrations as well as treatment engagement and retention. Applicants should fully consider the data collection needed to support the proposed project and budget for these project costs appropriately.

• Budget for travel expenses (airfare, hotel, per diem, and group transportation) for two staff to attend one face-to-face meeting each year for the life of the grant. Each meeting should be budgeted for 3 days each in Washington, D.C.

Allowable Uses of Funds for Subcategory 1a Grant funds under Subcategory 1a may be used to:

• Connect individuals at risk for overdose and/or survivors of a non-fatal overdose and their families with substance abuse and behavioral health treatment providers or peer recovery support. Peer recovery support services involve an array of supports and services that are responsive to the specific needs of the participant.

• Provide survivors of non-fatal overdoses with access to recovery support services.

• Provide prioritized—ideally immediate—access to detox and treatment services as well as access to medication-assisted treatment for the person experiencing addiction.

• Provide overdose prevention education and community outreach.

• Engage a research partner to conduct action research providing skills and assistance in identifying performance measures, tracking measures to assist in the improvement of program implementation and fidelity, providing subject expertise and guidance, performing performance evaluations, and/or ensuring outcomes are being evaluated effectively.

• Support the mandatory project coordinator position.

Allowable Uses of Funds for Subcategory 1b The crime victims’ field plays a critical role in supporting crime victims who are impacted by the opioid crisis. Due to the established link between trauma and substance abuse, many victim service providers are encountering increasingly complex issues within their day-to-day work— often interfacing with the same individuals and families that the first responders are encountering in moments of crisis. While many strong community partnerships and established multidisciplinary teams exist, linkages between first responders and victim service providers may not exist or could be strengthened to ensure that the comprehensive needs associated with substance abuse and victimization are addressed. Subcategory 1b is designed to support the incorporation of victim service and child welfare components into first responder and behavioral health and/or public health partnerships. Through these partnerships, BJA and OVC believe that those impacted by the opioid epidemic and those who are victimized will be provided a more comprehensive, long-term, and effective response.

Grant funds under Subcategory 1b may be used to support a combination of victim services and general services as outlined below.

Victim Services Funds may be used to:

• Fund victim service providers and other staff specially trained to meet the needs of children present at an overdose scene and/or impacted by drug use in the home.

• Provide a rapid response intervention program for children who witness a parent or loved one suffer an overdose in order to help children cope with trauma and build resiliency.

• Develop and provide specialized training to first responders, victim service providers, and child protective services professionals to ensure that there is an established process/protocol to follow when encountering a child or youth affected by overdose or in a home where the child is exposed to substance abuse.

• Respond to the specific needs of children impacted by a fatal or non-fatal overdose of a loved one (either as witnesses on the scene or as victims of abuse and neglect associated with a caretaker’s substance abuse).

• Support cross-system collaborative activities (e.g., multidisciplinary training, regular partnership meetings) to increase understanding among the different service systems about issues facing families involved in child protective services due to a parent’s substance abuse.

• Provide immediate and long-term support, resources, and services to crime victims— particularly children and families—to help them identify and attend to traumatic experiences, support them when in the criminal or civil justice systems, and develop long-term healthy coping strategies.

• Co-locate staff to assist with screening, assessment, referral, and/or the provision of services to children and families impacted by substance abuse.

• Provide training and information on resources to child and youth-serving organizations, such as schools, athletic leagues and faith-based organizations, on the impact of substance abuse on children, youth, and families.

• Implement a combination of evidence-based or evidence-informed programs and practices, including parenting and/or family strengthening, treatment for trauma or mental health problems, counseling and peer support groups, and child development services designed to support children and youth exposed to drug use and their caregivers.

General Services Funds may be used to:

• Connect individuals at risk for overdose and/or survivors of a non-fatal overdose and their families with substance abuse and behavioral health treatment providers or peer recovery support. Peer recovery support services involve an array of supports and services that are responsive to the specific needs of the participant.

• Provide survivors of non-fatal overdoses with access to recovery support services.

• Provide prioritized—ideally immediate—access to detox and treatment services as well as access to medication-assisted treatment for the person experiencing addiction.

• Provide overdose prevention education and community outreach.

• Engage a research partner to conduct action research providing skills and assistance in identifying performance measures, tracking measures to assist in the improvement of program implementation and fidelity, providing subject expertise and guidance, performing performance evaluations, and/or ensuring outcomes are being evaluated effectively.

Priority Consideration for Category 1 Priority consideration will be given to applicants that:

• Demonstrate they have been disproportionately impacted by the abuse of illicit opioids and prescription drugs as evidenced, in part, by high rates of primary treatment admissions for heroin and other opioids; high rates of overdose deaths from heroin and other opioids; and/or a lack of accessibility to treatment providers and facilities or to emergency medical services.

• Incorporate the use of Overdose Detection Mapping Application Program (ODMAP) data collection tools to track near real-time fatal and non-fatal overdose data. This information is designed to facilitate public safety, behavioral health, and/or public health partnerships, and help inform prevention, outreach, treatment and enforcement initiatives. Communities with existing data tracking systems that capture fatal and non-fatal overdose data can receive priority consideration by agreeing to also make data available through ODMAP.

• Include a research plan that will assist in the identification of the problem, design of the solution, and evaluation of the proposed initiative.

Category 2: Technology-assisted Treatment Projects The Technology-assisted Treatment Projects grant program is designed to pilot, in up to five states, projects that demonstrate how technology can be used to expand treatment and recovery support services to individuals who abuse illicit and prescription opioids and have limited access to treatment and recovery services due to geographic isolation. Applicants may propose the use of technology to allow staff to remotely conduct substance abuse assessments, develop and monitor case plans, monitor medication-assisted treatment, and/or deliver cognitive behavioral treatment.

Applicants under Category 2 may request a project period of 36 months and an award amount no greater than $1,000,000. The application budget must reflect the total requested funding amount for the entire grant period and not the request per year. Applicants should fully consider the partnerships required and budget for each partner’s project costs appropriately. Specifically, applicants should fully consider the data collection needed to support the proposed project and appropriately budget for this project cost.

Mandatory Project Components and Deliverables for Category 2 All applicants under Category 2 must:

• Submit letters of support and/or an interagency agreement from the State Administering Agency (SAA) responsible for directing criminal justice planning and coordination and the Single State Agency (SSA) for Substance Abuse Services indicating that they have agreed to partner on this project. The letters or interagency agreement should clearly articulate the level of involvement each agency will have in the proposed project.

• Document the impact of the opioid epidemic based on local, regional, or state-level data.

• Propose to pilot technology-assisted treatment projects in at least three sites within the applicant state.

• Document at least one partner with experience providing services to rural communities.

• Document the rural nature of the state, as appropriate, and the challenges related to treatment access.

• Identify a project coordinator who must have dedicated time set aside, beyond their normal job duties, to manage the day-to-day operations of the initiative during the planning and implementation phases. No less than 50 percent of the project coordinator’s time should be spent on BJA-funded project activities. The project coordinator will be required to work closely with designated BJA COAP TTA providers to:

o Identify the needs of the community, including collecting and analyzing administrative data.

o Work with project staff to design an appropriate implementation strategy based https://ojp.gov/saa/ http://www.samhsa.gov/sites/default/files/ssadirectory.pdf on the data.

o Convene regular stakeholder discussions surrounding project implementation.

o Respond to requests for data, reports, and information about the proposed initiative.

o Ensure continued project implementation and redirection if needed.

• Agree to work closely with BJA’s designated TTA provider(s) as well as an evaluator who may conduct a site specific or cross-site evaluation in future years.

• Track quarterly performance measures. Applicants should fully consider the data collection needed to support the proposed project and budget for these project costs appropriately.

• Budget for travel expenses (airfare, hotel, per diem, and group transportation) for a minimum of two staff to attend one face-to-face meeting each year of the life of the grant. Each meeting should be budgeted for 3 days each in Washington, D.C.

Allowable Uses of Funds for Category 2 Grant funds may be used to support a combination of the allowable use categories below, or be concentrated on one specific area:

• Purchase technology—including equipment, hardware, and software—to establish a secure and private two-way, real time, interactive audio and video connection between a qualified treatment provider and a client located at another location. This includes the purchase of computer hardware and software as well as audio and video equipment.

Proposed expenses should be reasonable and limited to what is necessary to support the project.

• Purchase hardware and software needed to implement web-based behavioral interventions to treat substance abuse. Applicants should review existing technology-assisted care products (see http://sudtech.org/) developed by the National Institute on Drug Abuse (NIDA) and SAMHSA when designing their programs.

• Provide training and staff support to manage the proposed project or provide services.

• Develop, purchase, and/or maintain web-based services and electronic applications that can be accessed from computers, tablets, and/or smart phone devices that are designed to enhance or support treatment and recovery support services (e.g., apps for self-management through reminders and educational prompts). Support for this area cannot exceed 10 percent of the total proposed budget.

• Purchase or lease devices that allow for the remote monitoring of offenders (e.g., applications or services that remotely monitor the location of an individual or monitor the use of substances remotely). Support for this area cannot exceed 10 percent of the total proposed budget.

• If the proposed project is part of a diversion program, funds may be used to develop or support remote, secure, and private two-way, real time, interactive audio and video connections between the supervision officer and the offender located at another location.

Support for this area cannot exceed 20 percent of the total proposed budget.

• Support the mandatory project coordinator position.

Grant funds may not be used to:

• Support services such as telephone conversations, electronic mail messages, or facsimile transmissions as the primary proposed intervention.

Priority Consideration for Category 2 Priority consideration will be given to applicants that:

http://sudtech.org/

• Demonstrate the state, or regions within the state, have been disproportionally impacted by the abuse of illicit opioids and prescription drugs as evidenced, in part, by high rates of primary treatment admissions for heroin and other opioids; high rates of overdose deaths from heroin and other opioids; and/or a lack of accessibility to treatment providers and facilities and to emergency medical services.

• Are rural states where communities have limited resources.

Category 3: System-level Diversion Projects Applicants must demonstrate a commitment to establish effective diversion programs for offenders who abuse illicit or prescription opioids. Category 3 applicants may propose projects that support pretrial diversion, court-based diversion programs (other than drug courts or Veterans treatment courts, which are funded under a separate BJA solicitation), community-based supervision, corrections programs, and/or reentry programs. .

Jurisdictions without a county or local government-based addiction service system may designate the SSA to serve as the primary applicant and subgrant funds to providers at the community level. Additionally, tribal governments may propose a reservation- or tribal-region-wide approach, as appropriate.

Applicants under Category 3 may request a project period of 36 months and an award amount no greater than $900,000. The application budget must reflect the total requested funding amount for the entire grant period and not request per year. Applicants should fully consider the partnerships required, the logistics of establishing data sharing or data use agreements to support the proposed project, and budget for each partner’s project costs appropriately.

Specifically, applicants should fully consider the data collection needed to support the proposed project and appropriately budget for this project cost.

Mandatory Project Components and Deliverables for Category 3 All applicants under Category 3 must:

• Establish a team (or utilize a pre-existing team) of stakeholders from across government and the community to engage in the planning process. The appropriate composition of the team may vary, based on the proposed project, but should generally include representatives from county administration; public health; health care providers;

substance abuse treatment agencies; law enforcement; the local pretrial agency; adult probation and parole; juvenile probation; the trial courts; the adult, juvenile, family, tribal and problem-solving courts; child welfare; corrections administrators; and nonprofit organizations that provide wraparound or recovery support services. Applicants must provide a letter of support and/or an interagency agreement documenting each agency’s commitment to participating in the planning and implementation processes. The letters or interagency agreement should clearly articulate the level of involvement each agency will have in the proposed project.

• Document the impact of the opioid epidemic based on local, regional, or state-level data.

• Identify a project coordinator who must have dedicated time set aside beyond their normal job duties to manage the day-to-day operations of the project during the planning and implementation phases. No less than 50 percent of the project coordinator’s time should be spent on BJA-funded project activities. The project coordinator will work closely with designated COAP TTA provider(s) to:

o Identify the needs of the community, including collecting and analyzing administrative data.

o Work with project staff to design an appropriate outreach and prevention strategy based on data.

o Convene regular stakeholder discussions on project implementation.

o Respond to requests for data, reports, and information about the proposed project.

o Ensure continued project implementation and redirection if needed.

• Agree to work closely with BJA’s designated TTA provider(s), as well as an evaluator who may conduct a site-specific or cross-site evaluation in future years.

• Track quarterly performance measures. Applicants should fully consider the data collection needed to support the proposed project and appropriately budget for this project cost.

• Budget for travel expenses (airfare, hotel, per diem, and group transportation) for a minimum of two staff to attend one face-to-face meeting each year of the grant. Each meeting should be budgeted for 3 days each in Washington, D.C.

Allowable Uses of Funds for Category 3 Grant funds must be used to serve individuals at any intercept point. Grant funds may be used to support a combination of the allowable use categories below, or be concentrated on one of the following specific areas:

• Establish court-based intervention programs or family court programming to prioritize and expedite treatment and recovery services to individuals at high risk for overdose.

Funding is available under other BJA solicitations to implement or enhance an adult drug court and/or a veteran treatment court. As such, implementing or enhancing these court models is not an allowable funding activity under this solicitation.

• Develop, implement, or enhance programs to address the opioid epidemic in tribal communities.

• Link high frequency drug users with evidence-based treatment and recovery support services, with the goal of reducing overreliance on emergency health care and encounters with the criminal justice system.

• Implement a plan to universally screen offenders entering community-based supervision and/or jail for risk of overdose and prioritize services to these offenders.

• Develop and implement a comprehensive plan to reduce the risk of overdose death and enhance treatment and recovery service engagement among the pretrial and post-trial populations leaving jails or secure residential treatment facilities.

• Implement or expand the system wide use of recovery support services using peer recovery coaches.

• Expand the use of cognitive behavioral treatment, in combination with medication-assisted treatment, to help offenders engage in the treatment process, modify their attitudes and behaviors related to opioid abuse, and improve their life skills.

• Implement wraparound services that facilitate meaningful coordination between the justice system and family support agencies, especially child welfare, to safeguard the lives and wellbeing of children and family members who experience the impacts of opioid abuse. These initiatives may focus on improving parental functioning or engaging family members as a natural support system at all points in the justice system. Applicants are encouraged to review the National Center on Substance Abuse and Child Welfare (NCSACW) website at https://ncsacw.samhsa.gov for additional information and incorporate these concepts into their grant applications.

• Establish collaborative public health and justice partnerships to address the unique needs of women in the criminal justice system who abuse illicit or prescription https://ncsacw.samhsa.gov/ opioids, including pregnant women.

• Develop data or information systems to facilitate analyses, help track progress, and assist in efforts to report on outcomes.

• Implement other comprehensive approaches that serve individuals within more than one intercept and align with the objectives of COAP.

• Support the mandatory project coordinator position.

• Engage a research partner to conduct action research providing skills and assistance in identifying performance measures, tracking measures to assist in the improvement of program implementation, providing subject expertise and guidance, performing performance evaluations, and/or ensuring outcomes are being evaluated effectively.

Priority Consideration for Category 3 Priority consideration will be given to applicants that:

• Demonstrate that they have been disproportionately impacted by the abuse of illicit opioids and prescription drugs as evidenced, in part, by high rates of primary treatment admissions for heroin and other opioids; high rates of overdose deaths from heroin and other opioids; and/or a lack of accessibility to treatment providers and facilities and to emergency medical services.

• Include a research plan that will assist in the identification of the problem, design of the solution, and evaluation of the proposed initiative.

Category 4: Statewide Planning, Coordination, and Implementation Projects Category 4 statewide planning, coordination, and implementation projects are designed to support initiatives jointly planned and implemented by the State Administering Agency (SAA) responsible for directing criminal justice planning and the Single State Agency (SSA) for Substance Abuse Services. Either the SAA or the SSA may be the applicant. The application must contain a letter of support or an interagency agreement from both entities that outlines each agency’s commitment to the project in order to be eligible.

Category 4 contains two subcategories of funding. Subcategory 4a funds the development of a coordinated plan between the SAA and the SSA to assist localities in engaging and retaining offenders who abuse illicit or prescription opioids in treatment and recovery services; increase the use of diversion; and/or reduce the incidence of overdose death. In addition to supporting the development of a coordinated plan, which is a mandatory project deliverable of Category 4a, applicants may propose training and/or technical assistance programs for localities geared toward improving treatment engagement and client outcomes; tracking, compiling, coordinating, and disseminating statewide and local data; or increasing communication, coordination, and information sharing among state and local programs.

Subcategory 4b enables the applicant to provide financial support to localities or a region to implement the strategies in the plan developed as part of Category 4a. These strategies may focus on supporting treatment and recovery service engagement; increasing the use of diversion; and/or supporting initiatives that reduce the incidence of overdose death.

Applicants may apply for Subcategory 4a (up to $100,000) for a 24-month period or Subcategory 4b (up to $1,200,000) for a 36-month period separately; however, it is suggested that applicants apply for both and maximize funds available from each category (for up to $1,300,000) to assist with state-based coordination, planning, and training.

http://www.samhsa.gov/sites/default/files/ssadirectory.pdf

Applicants that already have an existing state plan, jointly developed by the SAA and the SSA, may choose to apply for Subcategory 4b without applying for Subcategory 4a. Applicants should clearly indicate in their applications whether they are applying for Subcategory 4a, Subcategory 4b, or Subcategories 4a and 4b. Those applicants applying for both Subcategories 4a and 4b should submit one application including both categories.

Applicants should fully consider the partnerships required, the logistics of establishing data sharing or data use agreements to support the proposed project, and appropriately budget for each partner’s project costs. The application budget must reflect the total requested funding amount for the entire grant period and not request per year.

All federal funds under Subcategory 4b must be passed through to localities within the state except 10 percent of the grant award that may be retained for administrative purposes. States that have no county or local government-managed addiction service system may contract funds directly to providers at the community level.

Mandatory Project Components and Deliverables for Category 4 All applicants under Category 4 must:

• Provide a letter of support or an interagency agreement from both the SAA responsible for directing criminal justice planning and coordination and the SSA for Substance Abuse Services. These letters should clearly articulate the level of involvement each agency will have in the proposed project.

• Document the impact of the opioid epidemic, based on local-, regional-, or state-level data.

• Agree to work closely with BJA’s designated TTA provider(s), as well as an evaluator who may conduct a site-specific or cross-site evaluation in future years.

• Track quarterly performance measures. Applicants should fully consider the data collection needed to support the proposed project and budget for these project costs appropriately.

• Budget for travel expenses (airfare, hotel, per diem, and group…

This is the start of the file's text. The full file is on GovTribe.

File details come from the government source that posted it.